OncLive® Scientific Interchange and Workshop Podcast Series: Treatment Updates in HER2+ Breast Cancer

home / scientific-interchange-and-workshop / onclive-scientific-interchange-and-workshop-podcast-series-treatment-updates-in-her2-breast-cancer

In this 3-part podcast series from a previously recorded event, Virginia Kaklamani, MD, DSc, is joined by community medical oncologists to discuss the remaining unmet needs in the management of HER2-positive breast cancer, and the treatment of early and advanced stage HER2-positive breast cancer.

Remaining Unmet Needs in the Treatment of HER2-Positive Breast Cancer

EP. 1: Remaining Unmet Needs in the Treatment of HER2-Positive Breast Cancer

May 26th 2021

In the first segment, Dr Kaklamani and colleagues discuss the remaining unmet needs clinicians face despite recent advances in the treatment of patients with HER2-positive breast cancer.

Neoadjuvant and Adjuvant Treatment of HER2-Positive Breast Cancer

EP. 2: Neoadjuvant and Adjuvant Treatment of HER2-Positive Breast Cancer

May 26th 2021

Dr Kaklamani and colleagues take an in-depth look at data from select clinical trials in the neoadjuvant and adjuvant settings for patients with HER2-positive breast cancer.

Treatment of Metastatic HER2-Positive Breast Cancer

EP. 3: Treatment of Metastatic HER2-Positive Breast Cancer

May 26th 2021

Dr Kaklamani and colleagues highlight key clinical trials such as DESTINY-Breast01, HER2CLIMB, NALA, and SOPHIA in the setting of advanced HER2-positive breast cancer and discuss the practical considerations of these data.